NAUTILUS BIOTECHNOLOGY INC. - COMMON STOCK

Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026

15 Oct 2026 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay

08 Jan 2026 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging

03 Nov 2025 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Third Quarter 2025 Financial Results

28 Oct 2025 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025

07 Oct 2025 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in Upcoming September Investor Conferences

27 Aug 2025 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Second Quarter 2025 Financial Results

31 Jul 2025 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics

30 Jul 2025 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025

15 Jul 2025 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

27 May 2025 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Reports First Quarter 2025 Financial Results

29 Apr 2025 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025

16 Apr 2025 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results

27 Feb 2025 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference

18 Feb 2025 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

06 Feb 2025 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award

31 Oct 2024 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference

30 Oct 2024 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Third Quarter 2024 Financial Results

29 Oct 2024 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024

08 Oct 2024 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer

17 Sep 2024 08:00:01 Источник Nasdaq GlobeNewswire